Multitarget agents for the treatment of Alzheimers disease

13th World congress on Alzheimers and Dementia
December 06-07, 2018 Amsterdam, Netherlands

Bachurin Sergey, V Sokolov, A Aksinenko V Grigoriev, G Makhaeva and E Shevtsov

Institute of Physiologically Active Compounds, Russia

ScientificTracks Abstracts: J Neurol Neurosci

DOI: 10.21767/2471-8548-C1-002


During past 15 years, any new agent that was investigated in clinical trials on Alzheimer’s disease (AD) patients has not been approved in the market. One of the main problems in successful development of the agents for CNS neurodegenerative disorders treatment related to multifactorial nature of such diseases. In this relation. design of multitarget drugs was focused that simultaneously act on several biotargets connected to pathogenesis of neurodegenerative diseases looks as a promising strategy for developing new generation of neuroprotective CNS agents. In the present work, we present the results of design and synthesis of novel polypharmacophore agents superposing in one molecule several structural pharmacophore fragments of already validated neuroprotective agents. In particular, synthesis and study of conjugates of phenothiazine (methylene blue) and gamma-carboline (Dimebon) derivatives, as well as conjugates of adamantine (memantine) and carbazole derivatives was performed. Currently several lead-compounds successfully passed preclinical trials and ready to be moved on further clinical study.


Bachurin Sergey has completed his PhD and Dr. Sci degree from Moscow State University, Russia. He had been working in the University of San Francisco and in Taft’s University (USA) in 1992 and in 1995. Since 2006, he is serving as the Director of the Institute of Physiologically Active Compounds, Russian Academy of Science in Chernogolovka, Russia, and the Head of the Department of Medicinal and Biological Chemistry. He has published more than 220 papers in reputed journals and about 40 patents, and has been serving as an Editorial Board Member of repute.

E-mail: [email protected]

17+ Million Readerbase
Recommended Conferences
Google Scholar citation report
Citations : 22

Journal of Neuropsychiatry received 22 citations as per Google Scholar report

Abstracted/Indexed in
  • Google Scholar
  • China National Knowledge Infrastructure (CNKI)
  • Secret Search Engine Labs
  • Euro Pub

View More »

Flyer image

agar io

wormax io